Benzoyl peroxide is a popular and effective treatment for mild to moderate acne. However, its irritating side effects, especially for those with sensitive skin, can limit its usability. Now, a new delivery system promises to make benzoyl peroxide treatments more accessible and gentle. SkinMedica is launching NeoBenz Micro, a prescription-only acne treatment designed to minimize irritation while maintaining effectiveness.
NeoBenz Micro utilizes a time-release formula with tiny ‘sponges’ called microspheres. These microspheres gradually release benzoyl peroxide throughout the day, providing continuous treatment with significantly reduced irritation. The treatment is available in three strengths: 3.5%, 5.5%, and 8.5% benzoyl peroxide, allowing doctors to prescribe the most appropriate dosage for individual needs.
Traditional benzoyl peroxide treatments often cause rashes, soreness, and irritation, which can decrease their effectiveness as patients discontinue use. NeoBenz Micro aims to combat these side effects, improving patient compliance and outcomes.
NeoBenz Micro represents a growing trend in the pharmaceutical industry: refining existing treatments for better delivery and patient experience. Rather than solely focusing on discovering entirely new compounds, companies are innovating by improving how proven medications are administered. Examples include converting treatments into spray form for increased absorption and convenience. MedPharm, a research firm, is currently developing spray versions of an eczema treatment and two other acne treatments.
This shift towards optimizing existing treatments signifies a move towards patient-centric care, prioritizing comfort and ease of use without sacrificing efficacy.